GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types

(MedPage Today) — CHICAGO — Use of GLP-1 receptor agonists in patients with four types of solid tumors was significantly associated with lower rates of progression to metastatic disease over a 5-year period, according to a propensity score-matched analysis…